Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
13.58 (1y: +57%)
Market Cap 277.01 M P/E(ttm)
Enterprise Value 190.18 M P/B 1.80
PMTI- NAS (USA)
Palomar Medical Technologies Inc.
  • Currently 1/5
Business Predictability Rank: 1-Star (On Watch)
Back Testing Results:
Average gain of all 1-Star stocks: 1.1% per year.
% of Stocks that are in still loss if held for 10yrs: 45%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies
$13.58
Switch to:

GuruFocus Financial Strength Rank measures how strong a companyย’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry		 vs
history
Cash to Debt No Debt
PMTI's Cash to Debt is ranked higher than
81% of the 366 Companies
in the Global Medical Devices industry.

( Industry Median: 1.80 vs. PMTI: No Debt )
PMTI' s 10-Year Cash to Debt Range
Min: 3.88   Max: No Debt
Current: No Debt
Equity to Asset 0.892
PMTI's Equity to Asset is ranked higher than
95% of the 366 Companies
in the Global Medical Devices industry.

( Industry Median: 0.60 vs. PMTI: 0.892 )
PMTI' s 10-Year Equity to Asset Range
Min: 0.3   Max: 0.89
Current: 0.89
0.3
0.89
Interest Coverage No Debt
PMTI's Interest Coverage is ranked higher than
79% of the 366 Companies
in the Global Medical Devices industry.

( Industry Median: 9.60 vs. PMTI: No Debt )
PMTI' s 10-Year Interest Coverage Range
Min: No Debt   Max: No Debt
Current: No Debt
F-Score: 2
Z-Score: 8.86
M-Score: -1.76
GuruFocus Profitability Rank ranks how profitable a company is and how likely the companyย’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
ย•ย•3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rankย•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry		 vs
history
Operating margin (%) -7.40
PMTI's Operating margin (%) is ranked lower than
58% of the 366 Companies
in the Global Medical Devices industry.

( Industry Median: 5.40 vs. PMTI: -7.40 )
PMTI' s 10-Year Operating margin (%) Range
Min: -98.4   Max: 34.2
Current: -7.4
-98.4
34.2
Net-margin (%) -7.7
PMTI's Net-margin (%) is ranked lower than
57% of the 366 Companies
in the Global Medical Devices industry.

( Industry Median: 2.50 vs. PMTI: -7.7 )
PMTI' s 10-Year Net-margin (%) Range
Min: -72.8   Max: 103.3
Current: -7.7
-72.8
103.3
ROE (%) -4.1
PMTI's ROE (%) is ranked lower than
58% of the 366 Companies
in the Global Medical Devices industry.

( Industry Median: 3.80 vs. PMTI: -4.1 )
PMTI' s 10-Year ROE (%) Range
Min: -140.4   Max: 146.8
Current: -4.1
-140.4
146.8
ROA (%) -3.7
PMTI's ROA (%) is ranked lower than
56% of the 366 Companies
in the Global Medical Devices industry.

( Industry Median: 2.00 vs. PMTI: -3.7 )
PMTI' s 10-Year ROA (%) Range
Min: -45.7   Max: 72.1
Current: -3.7
-45.7
72.1
ROC (Joel Greenblatt) (%) -11.00
PMTI's ROC (Joel Greenblatt) (%) is ranked lower than
59% of the 366 Companies
in the Global Medical Devices industry.

( Industry Median: 9.60 vs. PMTI: -11.00 )
PMTI' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -23.6   Max: 680.8
Current: -11
-23.6
680.8
Revenue Growth (%) 6.3
PMTI's Revenue Growth (%) is ranked higher than
85% of the 366 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. PMTI: 6.3 )
PMTI' s 10-Year Revenue Growth (%) Range
Min: -14.5   Max: 30.2
Current: 6.3
-14.5
30.2
EBITDA Growth (%) -10.3
PMTI's EBITDA Growth (%) is ranked lower than
63% of the 366 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. PMTI: -10.3 )
PMTI' s 10-Year EBITDA Growth (%) Range
Min: -10.3   Max: 207.1
Current: -10.3
-10.3
207.1
EPS Growth (%) -13.1
PMTI's EPS Growth (%) is ranked lower than
60% of the 366 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. PMTI: -13.1 )
PMTI' s 10-Year EPS Growth (%) Range
Min: 0   Max: 87.9
Current: -13.1
0
87.9
ยป PMTI's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades
Q2 2012

PMTI Guru Trades in Q2 2012

Charles Brandes 188,503 sh (+53.38%)
Jim Simons 198,769 sh (+20.58%)
Mario Gabelli 274,400 sh (+2.93%)
John Buckingham 434,616 sh (-2.46%)
» More
Q3 2012

PMTI Guru Trades in Q3 2012

Jim Simons 194,169 sh (-2.31%)
Mario Gabelli 263,900 sh (-3.83%)
John Buckingham 390,952 sh (-10.05%)
Charles Brandes 29,718 sh (-84.23%)
» More
Q4 2012

PMTI Guru Trades in Q4 2012

Jim Simons 190,769 sh (-1.75%)
Mario Gabelli 247,900 sh (-6.06%)
John Buckingham 367,117 sh (-6.1%)
Charles Brandes 23,258 sh (-21.74%)
» More
Q1 2013

PMTI Guru Trades in Q1 2013

Jean-Marie Eveillard 84,797 sh (New)
Mario Gabelli 253,900 sh (+2.42%)
Charles Brandes Sold Out
John Buckingham Sold Out
Jim Simons 181,800 sh (-4.7%)
» More
» Details

Insider Trades

Latest Guru Trades with PMTI

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Charles Brandes 2013-03-31 Sold Out $9.21 - $13.49 $ 13.5825%0
Jean-Marie Eveillard 2013-03-31 New Buy$9.21 - $13.49 $ 13.5825%84797
Charles Brandes 2012-12-31 Reduce -21.74%$7.18 - $9.32 $ 13.5857%23258
Charles Brandes 2012-09-30 Reduce -84.23%0.01%$7.83 - $9.65 $ 13.5857%29718
Charles Brandes 2012-06-30 Add 53.38%0.01%$8.05 - $9.83 $ 13.5857%188503
Charles Brandes 2012-03-31 Add 258.63%0.01%$9.03 - $11.04 $ 13.5849%122903
Michael Price 2011-09-30 Sold Out 0.2506%$7.31 - $11.81 $ 13.5850%0
Mario Gabelli 2011-09-30 Add 22.87%$7.31 - $11.81 $ 13.5850%255200
Charles Brandes 2011-06-30 Add 99.07%$9.65 - $16.01 $ 13.584%35495
Mario Gabelli 2011-03-31 Reduce -61.56%0.03%$13.33 - $16.48 $ 13.58-9%175700
Charles Brandes 2011-03-31 Reduce -87.89%$13.33 - $16.48 $ 13.58-9%17830
Michael Price 2010-12-31 Add 36.48%0.1%$10.22 - $14.94 $ 13.5814%153106
Michael Price 2010-09-30 New Buy0.24%$8.73 - $11.71 $ 13.5835%112182
Mario Gabelli 2010-09-30 Add 318.59%0.02%$8.73 - $11.71 $ 13.5835%457100
Mario Gabelli 2010-06-30 Reduce -73.12%0.01%$9.7 - $13.47 $ 13.5818%109200
Premium More recent guru trades are included for Premium Members only!!
ยป Financial Charts

Peter Lynch Chart

Top Ranked Articles about Palomar Medical Technologies Inc.

Weekly CFO Sells Highlight: HAIN, PMTI, LTD, STZ, GDOT
June 3, 2013
According to GuruFocus Insider Data, the largest CFO sells for the past week were: Hain Celestial Group Inc., Palomar Medical Technologies Inc., L Brands Inc., Constellation Brands Inc. and Green Dot Corp. Read more...

Ratios

vs
industry		 vs
history
P/B 1.80
PMTI's P/B is ranked higher than
72% of the 307 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. PMTI: 1.80 )
PMTI' s 10-Year P/B Range
Min: 0.77   Max: 20.24
Current: 1.8
0.77
20.24
P/S 3.02
PMTI's P/S is ranked higher than
54% of the 333 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. PMTI: 3.02 )
PMTI' s 10-Year P/S Range
Min: 0.45   Max: 10.86
Current: 3.02
0.45
10.86
PFCF 123.40
PMTI's PFCF is ranked lower than
63% of the 200 Companies
in the Global Medical Devices industry.

( Industry Median: 21.03 vs. PMTI: 123.40 )
PMTI' s 10-Year PFCF Range
Min: 9.86   Max: 1.61217E+18
Current: 123.4
9.86
1.61217E+18
EV-to-EBIT 8.5
PMTI's EV-to-EBIT is ranked higher than
84% of the 220 Companies
in the Global Medical Devices industry.

( Industry Median: 18.50 vs. PMTI: 8.5 )
PMTI' s 10-Year EV-to-EBIT Range
Min: 4.4   Max: 107.7
Current: 8.5
4.4
107.7
Shiller P/E 414.8
PMTI's Shiller P/E is ranked lower than
100% of the Companies
in the Global Medical Devices industry.

( Industry Median: vs. PMTI: 414.8 )
PMTI' s 10-Year Shiller P/E Range
Min: 6.64   Max: 1958
Current: 414.8
6.64
1958

Valuation & Return

vs
industry		 vs
history
Price/Net Cash 3.9
PMTI's Price/Net Cash is ranked higher than
86% of the 90 Companies
in the Global Medical Devices industry.

( Industry Median: 10.50 vs. PMTI: 3.9 )
PMTI' s 10-Year Price/Net Cash Range
Min: 2.1   Max: 52.6
Current: 3.9
2.1
52.6
Price/Net Current Asset Value 12.1
PMTI's Price/Net Current Asset Value is ranked higher than
67% of the 264 Companies
in the Global Medical Devices industry.

( Industry Median: 14.30 vs. PMTI: 12.1 )
PMTI' s 10-Year Price/Net Current Asset Value Range
Min: 2.8   Max: 57.4
Current: 12.1
2.8
57.4
Price/Tangible Book 1.8
PMTI's Price/Tangible Book is ranked higher than
81% of the 272 Companies
in the Global Medical Devices industry.

( Industry Median: 3.90 vs. PMTI: 1.8 )
PMTI' s 10-Year Price/Tangible Book Range
Min: 1.1   Max: 15.8
Current: 1.8
1.1
15.8
Price/DCF (Projected) 2.4
PMTI's Price/DCF (Projected) is ranked higher than
54% of the 134 Companies
in the Global Medical Devices industry.

( Industry Median: 1.70 vs. PMTI: 2.4 )
PMTI' s 10-Year Price/DCF (Projected) Range
Min: 0.6   Max: 10.6
Current: 2.4
0.6
10.6
Price/Median PS Value 1.1
PMTI's Price/Median PS Value is ranked lower than
51% of the 284 Companies
in the Global Medical Devices industry.

( Industry Median: 0.90 vs. PMTI: 1.1 )
PMTI' s 10-Year Price/Median PS Value Range
Min: 0.2   Max: 3.1
Current: 1.1
0.2
3.1
Earnings Yield (Greenblatt) 11.80
PMTI's Earnings Yield (Greenblatt) is ranked higher than
93% of the 366 Companies
in the Global Medical Devices industry.

( Industry Median: 2.70 vs. PMTI: 11.80 )
PMTI' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.9   Max: 22.7
Current: 11.8
0.9
22.7
Forward Rate of Return (Yacktman) -1.46
PMTI's Forward Rate of Return (Yacktman) is ranked lower than
55% of the 366 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. PMTI: -1.46 )
PMTI' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -14.2   Max: 131.6
Current: -1.46
-14.2
131.6

Business Description

Palomar Medical Technologies Inc. was incorporated under the laws of the state of Delaware in 1987. The Company is a global medical device Company engaged in research, development, manufacturing and distribution of proprietary light-based systems for medical and cosmetic treatments. It has been developing a differentiated product mix of light-based systems for various treatments through its research and development as well as with its partnerships throughout the world. It is continually developing and testing new indications to further the advancement in light-based treatments. It offers a comprehensive range of products based on proprietary technologies that address various cosmetic issues, including: hair removal; body sculpting, including laser-assisted liposuction; removal of vascular lesions such as rosacea, spider veins, port wine stains and hemangiomas; wrinkle reduction; removal of leg veins; removal of benign pigmented lesions such as age and sun spots, freckles and melasma; tattoo removal; acne treatment; skin resurfacing; treatment of red pigmentation in hypertrophic and keloid scars; treatment of verrucae, skin tags, seborrheic keratosis; skin tightening through soft tissue coagulation; removal of scars, including acne scars, stretch marks and warts; and soft tissue coagulation. The Company conducts its manufacturing, warehousing, research and development, regulatory, sales, customer service, marketing and administrative activities. In the United States, Australia, Canada, Japan, Germany, and Spain, it market, sells, and service its products primarily through its direct sales force and customer service employees. In the rest of the world, sales are generally made through its worldwide distribution network in over 70 countries. The Company's main competitors include: Cutera, Inc., Cynosure, Inc., Solta, Syneron, Inc., Lumenis, Inc., Alma, Inc. and other smaller competitors. All of its current products are light-based devices, which are subject to FDA regulations for clinical testing, manufacturing, labeling, sale, distribution, and promotion.
Company Website
SEC Reports
Industry: Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ
Traded in other countries:PAL1.Germany
ยป More Articles for PMTI

Headlines

Articles On GuruFocus.com
Weekly CFO Sells Highlight: HAIN, PMTI, LTD, STZ, GDOT Jun 03 2013 
Palomar Medical Technologies Inc. Reports Operating Results (10-K) Mar 09 2011 
John Buckingham Buys Automatic Data Processing Inc., The Stanley Works, American Express Company, Se Apr 29 2010 
Palomar Medical Technologies Inc. (PMTI) Director, CEO & President Joseph P Caruso sells 12,473 Shar Dec 07 2009 
Palomar Medical Technologies Inc. (PMTI) CFO Paul S Weiner sells 9,979 Shares Dec 07 2009 
Palomar Medical Technologies Inc. Reports Operating Results (10-Q) Nov 05 2009 
Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 Feb 05 2009 

Personalized Checklist





Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK